In the IDO2-low group, thirty-three (66.4%) patients presented as pN0 stage, whereas only fourteen (18.2%) patients in the IDO2-high group had no lymph node metastasis. This evidence concerns the gene IDO2 and metastatic malignant neoplasm in the lymph nodes.